Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma × Anastrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 121 Carcinoma, Intraductal, Noninfiltrating 7 Neoplasm Metastasis 6 Breast Neoplasms, Male 4 Breast Carcinoma In Situ 4 Triple Negative Breast Neoplasms 3 Ovarian Neoplasms 3 Endometrial Neoplasms 3 Breast Diseases 3 Arthralgia 3 Advanced Breast Cancer 3 Neoplasms 2 Breast Cancer Metastatic 2 Solid Tumor 1 Sexual Dysfunction, Physiological 1 Seizures 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain 1 Osteoporosis 1 Obesity 1 Muscle Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Locoregional Recurrence 1 Invasive Breast Cancer 1 Hypogonadism 1 Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1 HER2-positive Breast Cancer 1

Interventions

Cisplatin 17 Gemcitabine 15 pembrolizumab 14 Radiotherapy 13 Paclitaxel 13 Radiotherapy, Intensity-Modulated 12 Carboplatin 10 Cyclophosphamide 9 Cetuximab 8 Magnetic Resonance Spectroscopy 7 Specimen Handling 6 Oxaliplatin 6 Fluorouracil 6 Docetaxel 6 Capecitabine 6 padeliporfin 5 Radiation 5 Irinotecan 5 Drug Therapy 5 poly ICLC 4 fludarabine 4 anlotinib 4 Standard of Care 4 Nivolumab 4 Leucovorin 4 Ipilimumab 4 Celecoxib 4 durvalumab 3 Sunitinib 3 Sorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02730923 2024-02-13

VICTORIA

Centre Leon Berard

Phase 1/2 Unknown

Carcinoma, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡